The BioZorb LP Marker is an implantable radiopaque marker used to facilitate visualization of a s...
FDA Device Recall #Z-1858-2022 — Class II — August 9, 2022
Recall Summary
| Recall Number | Z-1858-2022 |
| Classification | Class II — Moderate risk |
| Date Initiated | August 9, 2022 |
| Status | Ongoing |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Hologic, Inc |
| Location | Marlborough, MA |
| Product Type | Devices |
| Quantity | 233 |
Product Description
The BioZorb LP Marker is an implantable radiopaque marker used to facilitate visualization of a soft tissue site. The BioZorb LP Marker is comprised of a bioabsorbable PLA (polylactic acid) component which resorbs completely in 1 year or more and a permanent component (titanium). The BioZorb LP Marker is provided sterile for single use and is implantable.
Reason for Recall
Hologic BioZorb LP Marker, (Product number F0221), lot number 22A0RL, contained removable labels with an expiration date that indicated the product had already expired. The expiration date on the removable label is actually manufacturing date, and it's different from the one on the shelf box label, which is the correct expiration date.
Distribution Pattern
US Nationwide distribution including in the states of FL, IL, MD, NJ, AZ, TX, WA, VA, OK, NC, NH, GA, CA, CT, OH, CO, MI, MO, KS, TN, ID, MS, MT, AL, OR, IA, PA, MA.
Lot / Code Information
UDI-DI: 15420045514027 Lot 22A0RL Correct Expiration Date is July 8, 2024, but incorrect labels state expiration date of January 20, 2022.
Other Recalls from Hologic, Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1314-2026 | Class II | Brevera Breast Biopsy System Disposable 9 Gauge... | Dec 15, 2025 |
| Z-1093-2026 | Class II | ThinPrep¿ CytoLyt¿ Solution. Buffered Cell Wash... | Dec 12, 2025 |
| Z-1170-2025 | Class II | Brand Name: Sertera Biopsy Device Product Name... | Jan 15, 2025 |
| Z-0328-2025 | Class I | BioZorb Marker. Radiographic soft tissue marker. | Oct 10, 2024 |
| Z-1733-2024 | Class I | BioZorb Marker-BioZorb 3D Bioabsorbable Marker-... | Mar 13, 2024 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.